Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 610

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Hypersensitivity Cases Associated With Drug-Eluting Coronary Stents

Open access
Nebeker, Jonathan R., Virmani, Renu, Bennett, Charles L., Hoffman, Jennifer M., Samore, Matthew H., Alvarez, Jorge, Davidson, Charles J., McKoy, June M., Raisch, Dennis W., Whisenant, Brian K., Yarnold, Paul R., Belknap, Steven M., West, Dennis P., Gage, Jonathan E., Morse, Richard E., Gligoric, Gordana, Davidson, Laura, Feldman, Marc D.·2006·Journal of the American College of Cardiology

Abstract

OBJECTIVES We undertook the review of all available cases of hypersensitivity reactions after placement of a drug-eluting stent (DES) and classified potential causes. BACKGROUND Six months after the approval of the first DES, the Food and Drug Administration (FDA) reported 50 hypersensitivity reactions after stent placement but later concluded these were due to concomitantly prescribed medications such as clopidogrel. Nevertheless, the FDA continued to receive reports of hypersensitivity. METHODS Reports available from April 2003 through December 2004 for hypersensitivity-like reactions associated with the sirolimus-eluting stent (CYPHER, Cordis Corp., Miami Lakes, Florida) and paclitaxel-eluting stent (TAXUS, Boston Scientific Corp., Natick, Massachusetts) were reviewed. Sources of reports included the FDA's adverse-device-event database, the published literature, and investigators from the Research on Adverse Drug/Device events And Reports (RADAR) project. Causality was assessed using standardized World Health Organization criteria. RESULTS Of 5,783 reports identified for the DES in the FDA database, 262 unique events included hypersensitivity symptoms. Of these reports, 2 were certainly and 39 unlikely caused by clopidogrel and 1 was certainly, 9 probably, and 13 unlikely caused by the DES. From all sources, we identified 17 distinct cases that were probably or certainly caused by the stent, of which 9 had symptoms that lasted longer than four weeks. Four autopsies confirmed intrastent eosinophilic inflammation, thrombosis, and lack of intimal healing. CONCLUSIONS The FDA reports and autopsy findings suggest that DES may be a cause of systemic and intrastent hypersensitivity reactions that, in some cases, have been associated with late thrombosis and death.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2005.07.071

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 610

Metadata

Authors
Nebeker, J. R., Virmani, R., Bennett, C. L., Hoffman, J. M., Samore, M. H., Alvarez, J., Davidson, C. J., McKoy, J. M., Raisch, D. W., Whisenant, B. K., Yarnold, P. R., Belknap, S. M., West, D. P., Gage, J. E., Morse, R. E., Gligoric, G., Davidson, L., & Feldman, M. D.
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2006-01
Volume
47
Issue
1
Pages
175-181
ISSN
0735-1097 (ISSN-L)
OpenAlex
W1409723433
Cited by
610
References
1
FWCI
45.30
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hypersensitivity Cases Associated With Drug-Eluting Coronary Stents. https://app.cochat.ai/papers/10.1016/j.jacc.2005.07.071
The paper
Nebeker, J. R., Virmani, R., Bennett, C. L., Hoffman, J. M., Samore, M. H., Alvarez, J., Davidson, C. J., McKoy, J. M., Raisch, D. W., Whisenant, B. K., Yarnold, P. R., Belknap, S. M., West, D. P., Gage, J. E., Morse, R. E., Gligoric, G., Davidson, L., & Feldman, M. D. (2006). Hypersensitivity Cases Associated With Drug-Eluting Coronary Stents. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2005.07.071

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.